3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
11
Neoplasms
7
Leukemia, Myeloid, Acute
7
Lung Neoplasms
5
Ovarian Neoplasms
4
Fatigue
4
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Lymphoma
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Leukemia
2
Hematologic Neoplasms
2
Glioma
2
Genital Neoplasms, Female
2
Esophageal Neoplasms
2
Depression
2
Weight Loss
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Interventions
relacorilant
4
Hydrochlorothiazide
4
Nutrition Assessment
3
Labetalol
2
Bevacizumab
2
Angiotensin-Converting Enzyme Inhibitors
2
Amlodipine
2
ziprasidone
1
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
aliskiren
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hypertension
×
Palliative Care
×
Clear all
NCT04836221
2023-06-18
CARES
Medstar Health Research Institute
Phase NA
Completed
63 enrolled